• Home
• Generic Zopiclone
• Ambien Sleeping Tablets
• Diazepam Sleeping Tablets
• Datolan Sleeping Tablets
• Benadryl Sleeping Tablets
• Dormidina Sleeping Tablets
• Privacy Policy
• Terms & Conditions
• Site Links
• Site Map
• XML Sitemap
• ROR

• Sleep-Disorder-Diagnosis
• sleep-importants
• Sleeping-disorder-Causes
• Sleeping-disorder
• Sleep-disorder-Treatment
• Trouble sleeping
• What are sleep disorders?
• Sleep Disorders Overview
• Sleep Disorders
• About Sleep Disorders

This product is no longer available.

Dormidina ® 25 doxylamine succinate

COMPOSITION
Each Tablet contains: Doxylamine (INN) succinate……25 mg Excipients: dibasic calcium phosphate, microcrystalline cellulose, sodium starch glycolate, colloidal silicon dioxide, magnesium stearate, propylene glycol, titanium dioxide (E-171) blue coating (E-132), hidroxypropylmethyl cellulose, cellulose derivative and polyoxyl-40 stearate and polyethylene glycol 8000, q.s

PROPERTIES
Doxylamine, the active ingredient of Dormidina 25, has a quick acting sedative and sleep-inducing effect.

INDICATIONS
It is useful in the symptomatic treatment of all forms of insomnia, particularly associated with difficulties in falling asleep, frequent interruptions of sleep or early wakening. Its efficacy is already apparent after the first night time dose.

DOSAGE
The dose recommended for adults (over 18 years of age) is 1 tablet (25mg) given 30 minutes before going to bed. For young people under 18 years of age: consult your doctor.

CONTRAINDICATIONS
Dormidina 25 should not be used in people with asthma, glaucoma (increased intraocular pressure), prostate hypertrophy or patients with a history of hypersensitivity to any of its components. It should not be given to pregnant or lactating women.

PRECAUTIONS
It is recommended to take Dormidina 25 only when going to bed. Do not drive or handle dangerous machinery while taking this medicine.

WARNING
Use with caution if you drink alcohol or are taking medicines with ethanol as these may enhance the drug's sedative effect. It you are receiving treatment with another drug, you should consult your doctor before taking Dormidina 25. It should not be taken for periods exceeding 2 weeks or given to people under 18 years of age without the doctor's knowledge and recommendation.

Important for women: It you are pregnant or think you might be, consult your doctor before taking this medicine. The consumption of medicines during pregnancy may be dangerous for the embryo or foetus and should be monitored by your doctor.

It may interfere with skin tests that use allergens. It is recommended to stop taking this medication at least three days before starting these tests and that you inform your doctor.

INTERACTIONS
None have been described.

SIDE EFFECTS
Occasionally dry mouth and cloudy vision have been observed. In most cases, the side effects reported have been mild and have not required stopping treatment. If you feel drowsy the next morning, reduce the dose.

OVERDOSE AND ITS TREATMENT
In the event of massive intake, treatment should be symptomatic and aimed at maintaining vital functions, with endotracheal intubations if necessary. In the event of overdose or accidental intake, consult the Toxicological Information Service.

PRESENTATION
Boxes containing 16 coated Tablets with 25 mg.

OTHER PRESENTATIONS
Dormidina 12,5. Boxes containing 16 coated Tablets with 12,5 mg. Dormidina sachets. Boxes with 10 sachets containing effervescent powder with 25 mg.